Qubit Pharmaceuticals

Qubit Pharmaceuticals is a Paris-based, private biotech firm pioneering a quantum-aided drug discovery platform. The company integrates decades of computational chemistry research into its ATLAS platform, which uses quantum mechanics, AI, and hybrid HPC/quantum computing to generate and simulate novel drug candidates with high precision. With a team of over 60 experts and a pipeline of over 20 programs, Qubit is targeting historically undruggable targets in oncology and inflammation while actively seeking partnerships to expand its impact.

ATLAS platform: A quantum, AI, and physics-inspired platform for high-precision molecular modeling and simulation. It integrates quantum mechanics calculations (DFT, QMC, FCI), polarizable force field molecular dynamics, AI for chemical space exploration, and hybrid HPC-quantum computing capabilities to design and optimize drug candidates.

Qubit competes in the crowded AI/ML drug discovery sector against companies like Schrödinger, Recursion, Exscientia, and Relay Therapeutics. Its key differentiator is the deep integration of quantum physics principles and hybrid quantum computing readiness, positioning it in a more specialized, high-compute niche. However, this also means it faces competition from quantum computing companies (e.g., QC Ware, Zapata) exploring life sciences applications.